Technical Analysis for SCPH - scPharmaceuticals Inc.

Grade Last Price % Change Price Change
grade B 5.14 20.94% 0.89
SCPH closed up 13.64 percent on Tuesday, July 16, 2019, on 1.47 times normal volume. The stock crossed above its 200 day moving average, improving its long-term outlook by crossing above that critical trendline. Note that the stock is in overbought territory based on its Slow Stochastic indicator (14, 3, 3) -- sideways movement or a pullback should not be unexpected.

Trend Table & Recent Signals
ADX Long-Term Intermediate-Term Short-Term
Weak or Absent Up Up Up
See historical SCPH trend table...

Date Alert Name Type % Chg
Crossed Above 200 DMA Bullish 20.94%
Expansion Breakout Bullish Swing Setup 20.94%
Pocket Pivot Bullish Swing Setup 20.94%
Wide Bands Range Expansion 20.94%
Above Upper BB Strength 20.94%
Overbought Stochastic Strength 20.94%
Upper Bollinger Band Touch Strength 20.94%
Spinning Top Other 37.43%
Inside Day Range Contraction 37.43%
Overbought Stochastic Strength 37.43%

Older signals for SCPH ...

Free Daily (Stock) Chart Reading

Let us help you stay on top of your investments. We will alert you to important technical developments on your portfolio & watchlist.
Configure default chart indicators
Basic chart:
ScPharmaceuticals, Inc. is a United States-based biopharmaceutical company. The Company is engaged in developing pharmaceutical products for subcutaneous delivery. The Company offers sc2Wear Infusor, which is a small pump that attaches to the body using a standard medical adhesive. The sc2Wear Infusor injects the drug into the body slowly, similar to an intravenous (IV) drip. The sc2Wear Infusor includes features, such as two-component design, automated safety features and micropiston pump technology. Its pipeline includes product timelines for preclinical, through regulatory approval. Its products will be administered subcutaneously through the sc2Wear Infusor. Its lead products are subcutaneous formulations of furosemide (parenteral diuretic in treating heart failure) and ceftriaxone (parenteral antibiotic outside the hospital setting). Its furosemide formulation has been optimized for use with the sc2Wear Infusor. Its pipeline also includes Ertapenem for subcutaneous delivery.
Medicine Biopharmaceutical Drugs Chemical Compounds Medication Pharmaceutical Products Dosage Forms Heart Failure Chloroarenes Injection Intravenous Therapy
Is SCPH a Buy, Sell or Hold?
Indicator Bull Case Neutral / Hold Bear Case
50 DMA
200 DMA
ADX Trend
Oversold / Overbought
Relative Strength
Summary: Counts: 3 bullish, 0 bearish and 2 neutral indicators. You may wish to incorporate that into your trading strategies.
Indicator Value
52 Week High 6.1
52 Week Low 2.44
Average Volume 73,519
200-Day Moving Average 3.8152
50-Day Moving Average 3.4532
20-Day Moving Average 3.4065
10-Day Moving Average 3.635
Average True Range 0.2991
ADX 20.28
+DI 28.3476
-DI 9.8863
Chandelier Exit (Long, 3 ATRs ) 3.4677
Chandelier Exit (Short, 3 ATRs ) 3.6773
Upper Bollinger Band 4.0149
Lower Bollinger Band 2.7981
Percent B (%b) 1.19
BandWidth 35.719947
MACD Line 0.1378
MACD Signal Line 0.0555
MACD Histogram 0.0823
Pivot Point Level Traditional / Classic Fibonacci Demark Woodie Camarilla
Resistance 4 (R4) 5.13
Resistance 3 (R3) 5.07 4.72 4.98
Resistance 2 (R2) 4.72 4.49 4.75 4.93
Resistance 1 (R1) 4.48 4.36 4.60 4.54 4.88
Pivot Point 4.13 4.13 4.19 4.16 4.13
Support 1 (S1) 3.90 3.91 4.02 3.96 3.62
Support 2 (S2) 3.55 3.77 3.58 3.57
Support 3 (S3) 3.31 3.55 3.52
Support 4 (S4) 3.37